Characterization of the discriminative stimulus effects of buprenorphine in pigeons

Psychopharmacology

Volumn 160, Issue 2, 2002, Pages 132-139

  Galici, Ruggero ^a   Brandt, Michael R ^a   France, Charles P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antagonism; Buprenorphine; Drug discrimination; Heroin; Naltrexone; Opioid; Pigeon; Time course; Tolerance

Indexed keywords

AMPHETAMINE; BUPRENORPHINE; BUTORPHANOL; COCAINE; DIAMORPHINE; ENADOLINE; KETAMINE; MORPHINE; NALBUPHINE; NALTREXONE; SPIRADOLINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ABUSE; DRUG ANTAGONISM; DRUG DISCRIMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; NONHUMAN; PIGEON; PRIORITY JOURNAL;

ANIMALS; BUPRENORPHINE; COLUMBIDAE; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; HEROIN; INJECTIONS; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; TIME FACTORS;

EID: 0036192468     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-001-0943-8     Document Type: Article

References (36)

1. Buprenorphine pharmacokinetic parameters during coronary artery bypass graft surgery
2. Some quantitative uses of drug antagonists
3. Buprenorphine treatment of opioid dependence
4. Assessment of buprenorphine in a drug discrimination procedure in humans
5. Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys
6. The discriminative stimulus effects of morphine in pigeons responding under a progressive ratio schedule of food presentation
7. Discriminative stimulus effects of BW373U86: A nonpeptide ligand with selectivity for delta opioid receptors
8. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent
9. In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions
10. Intravenous patient-controlled analgesia (PCA) in the treatment of postoperative pain: Rationale and clinical application
11. Discriminative stimulus effects of reversible and irreversible opiate agonists: Morphine, oxymorphazone and buprenorphine
12. Pharmacokinetics of morphine and its surrogates. X: Analyses and pharmacokinetics of buprenorphine in dogs
13. Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children
14. The interaction of buprenorphine with the opiate receptor: Lipophilicity as a determining factor in drug-receptor kinetics
15. Radioimmunoassay of buprenorphine with iodine label: Analysis of buprenorphine and metabolites in human plasma
16. Buprenorphine disposition in patients with renal impairment: Single and continuous dosing, with special reference to metabolites
17. Discriminative stimulus effects of buprenorphine in the rat
18. Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addiction
19. Buprenorphine and methoclocinnamox: Agonist and antagonist effects on respiratory function in rhesus monkeys
20. Differential binding properties of oripavines at cloned mu- and delta- opioid receptors
21. Substitution pharmacotherapies for opioid addiction: From methadone to LAAM and buprenorphine
22. Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings
23. Effects of drug discrimination history on the generalization of pentobarbital to other drugs
24. Buprenorphine treatment of cocaine and heroin abuse
25. Analgesic efficacy of peripheral opioids (all except intra-articular): A qualitative systematic review of randomized controlled trials
26. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: Influence of training dose, intrinsic efficacy and interanimal differences
27. Estimation in vivo of the receptor constants of morphine in naive and morphine-tolerant rats
28. Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination
29. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method
30. The guinea-pig ileum as an in vitro model to analyze dependence liability of narcotic drugs
31. The affinity of morphine for its pharmacologic receptor in vivo
32. Three-choice discrimination in pigeons is based on relative efficacy differences among opioids
33. Acute tolerance to the discriminative stimulus properties of morphine
34. Mu opioid receptor phosphorylation, desensitization and ligand efficacy